Warner Chilcott PLC (WCRX): Today's Featured Health Care Winner

Warner Chilcott ( WCRX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.1%. By the end of trading, Warner Chilcott rose 20 cents (1.1%) to $17.56 on average volume. Throughout the day, 2.7 million shares of Warner Chilcott exchanged hands as compared to its average daily volume of 3.2 million shares. The stock ranged in a price between $17.17-$17.60 after having opened the day at $17.23 as compared to the previous trading day's close of $17.36. Other companies within the Health Care sector that increased today were: Kips Bay Medical ( KIPS), up 16.1%, Tengion ( TNGN), up 15.2%, Metropolitan Health Networks ( MDF), up 12.8%, and AspenBio Pharma ( APPY), up 12.8%.

Warner Chilcott plc, a specialty pharmaceutical company, focuses on the development, manufacture, and promotion of branded pharmaceutical products in women's healthcare, gastroenterology, dermatology, and urology segments in North America and western Europe markets. Warner Chilcott has a market cap of $4.14 billion and is part of the drugs industry. The company has a P/E ratio of 13.3, below the average drugs industry P/E ratio of 14.5 and below the S&P 500 P/E ratio of 17.7. Shares are down 2.1% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Warner Chilcott a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Warner Chilcott as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, expanding profit margins, compelling growth in net income and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated.

On the negative front, Codexis ( CDXS), down 21.3%, Heska Corporation ( HSKA), down 15.8%, Sunshine Heart ( SSH), down 15.5%, and Senesco Technologies ( SNT), down 13.3%, were all laggards within the health care sector with BioMarin Pharmaceuticals ( BMRN) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%